검색어 : 통합검색[Vanderbilt Tom]
총 377건 중 377건 출력
, 35/38 페이지
-
341
- Impact of Age and Alberta Stroke Program Early Computed Tomography Score 0 to 5 on Mechanical Thrombectomy Outcomes : Analysis From the STRATIS Registry
- Zaidat, Osama O.; Liebeskind, David S.; Jadhav, Ashutosh P.; Ortega-Gutierrez, Santiago; Nguyen, Thanh N.; Haussen, Diogo C.; Yavagal, Dileep R.; Froehler, Michael T.; Jahan, Reza; Nogueira, Raul G.; Yao, Tom L.; Alenzi, Bader A.; Bushnaq, Saif; Mueller-Kronast, Nils H.; Neuroscience Institute, St Vincent Mercy Hospital, Toledo, OH (O.O.Z., S.B.).; Neurovascular Imaging Research Core and Stroke Center, Department of Neurology (D.S.L.), University of California Los Angeles.; Department of Neurology, University of Pittsburgh Medical Center, PA (A.P.J.).; Departments of Neurology, Neurosurgery and Radiology, University of Iowa Health Care, Carver College of Medicine (S.O.-G.).; Division of Interventional Neuroradiology and Interventional Neurology, Boston Medical Center, MA (T.N.N.).; Department of Neurology, Emory University, Atlanta, GA (D.C.H., R.G.N.).; Department of Neurology and Neurosurgery, University of Miami Miller School of Medicine, FL (D.R.Y.).; Cerebrovascular Program, Vanderbilt University Medical Center, Nashville, TN (M.T.F.).; Department of Radiology (R.J.), University of California Los Angeles.; Department of Neurology, Emory University, Atlanta, GA (D.C.H., R.G.N.).; Norton Neuroscience Institute, Norton Healthcare, Louisvill; (Stroke, v.52, 2021, pp.2220-2228)
-
342
- Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease : A Phase 2A Randomized Controlled Trial
- Cooper, Melisa; Cherney, David Z.I.; Greene, Tom H.; Heerspink, Hiddo J.L.; Jardine, Meg; Lewis, Julia B.; Wong, Muh Geot; Baquero, Elbalejandra; Heise, Mark; Jochems, Jeanine; Lanchoney, Diana; Liss, Charles; Reiser, David; Scotney, Pierre; Velkoska, Elena; Dwyer, Jamie P.; CSL Behring LLC, King of Prussia, Pennsylvania; Division of Nephrology, University of Toronto, Toronto, Ontario, Canada; Division of Biostatistics, University of Utah, Salt Lake City, Utah; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia; Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Renal Medicine, Concord Repatriation General Hospital, Sydney, New South Wales, Australia; CSL Behring LLC, King of Prussia, Pennsylvania; CSL Behring LLC, King of Prussia, Pennsylvania; CSL Behring LLC, King of Prussia, Pennsylvania; CSL Behring LLC, King of Prussia, Pennsylvania; CSL Behring LLC, King of Prussia, Pennsylvania; CSL Behring LLC, King of Prussia, Pennsylvania; CSL Ltd., Bio21 Institute, Melbourne, Victoria, Australia; CSL Ltd., Bio21 Institute, Melbo; (Journal of the American Society of Nephrology : JASN, v.35, 2024, pp.1546-1557)
-
343
- Antimicrobial Resistance Incidence and Risk Factors among <i>Helicobacter pylori</i> –Infected Persons, United States
- Duck, William M.; Sobel, Jeremy; Pruckler, Janet M.; Song, Qunsheng; Swerdlow, David; Friedman, Cindy; Sulka, Alana; Swaminathan, Balasubra; Taylor, Tom; Hoekstra, Mike; Griffin, Patricia; Smoot, Duane; Peek, Rick; Metz, David C.; Bloom, Peter B.; Goldschmid, Steven; Parsonnet, Julie; Triadafilopoulos, George; Perez-Perez, Guillermo I.; Vakil, Nimish; Ernst, Peter; Czinn, Steve; Dunne, Donald; Gold, Ben D.; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ; Howard University Medical Center, Washington, DC, USA; ; Vanderbilt University Medical Center, Nashville, Tennessee, USA; ; University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA; ; Atlanta Veterans Affairs Medical Center; (Emerging infectious diseases, v.10, 2004, pp.1088-1094)
-
344
- A Randomized Trial of an Intervention to Improve Self-Care Behaviors of African-American Women With Type 2 Diabetes
- Keyserling, Thomas C.; Samuel-Hodge, Carmen D.; Ammerman, Alice S.; Ainsworth, Barbara E.; Henrí quez-Roldá n, Carlos F.; Elasy, Tom A.; Skelly, Anne H.; Johnston, Larry F.; Bangdiwala, Shrikant I.; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Nutrition, Schools of Medicine and Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Nutrition, Schools of Medicine and Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Epidemiology and Biostatistics, Department of Exercise Science and Prevention Research Center, School of Public Health, University of South Carolina, Columbia, South Carolina; Department of Biostatistics, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Medicine, School of Medicine, Vanderbilt University, Nashville, Tennessee; School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, Ch; (Diabetes care, v.25, 2002, pp.1576-1583)
-
345
- KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and novel immunotherapy agents for advanced clear cell renal cell carcinoma (ccRCC).
- Suá rez, Cristina; Albiges, Laurence; Beckermann, Katy; Hammers, Hans J.; Stadler, Walter Michael; Miller Jr., Wilson H.; Rojas, Carlos; Peer, Avivit; Goh, Jeffrey C.; Park, Se Hoon; Waddell, Tom; Barthelemy, Philippe; Gajate, Pablo; Weickhardt, Andrew; Faust, Guy; Perini, Rodolfo F.; Bousserouel, Lockman; Wang, Ding; Motzer, Robert J.; Powles, Thomas; Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Gustave Roussy, Paris Saclay University, Paris, France; Vanderbilt University Medical Center, Nashville, TN; UT Southwestern Medical Center, Dallas, TX; The University of Chicago, Chicago, IL; Jewish General Hospital, Montré al, QC, Canada; Bradford Hill, Santiago, Chile; Rambam Medical Center, Haifa, Israel; Royal Brisbane & Women’s Hospital, Herston, QLD, Australia; Sungkyunkwan University, Samsung Medical Center, Seoul, Korea, Republic of; The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, Institut de Cancé rologie Strasbourg Europe (ICANS), Strasbourg, France; Medical Oncology Department, Hospital Universitario Ramó n y Cajal, Madrid, Spain; Olivia Newton-John Cancer Wellness & Research Centre, Heidelberg, VIC, Australia; University Hospitals of Leicester NHS Trust, Leiceste, United Kingdom; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.43, 2025, pp.552-552)
-
346
- Optimal Fixation Strategies for Displaced Femoral Neck Fractures in Patients 18-59 Years of Age: An Analysis of 565 Cases Treated at 26 Level 1 Trauma Centers
- Roser, Tom; Collinge, Cory A.; Giga, Kashmeera; Lebus, George F.; Beltran, Michael J.; Crist, Brett; Sems, Stephen A.; Gardner, Michael J.; Sagi, H. Claude; Archdeacon, Michael T.; Mir, Hassan R.; Rodriguez-Buitrago, Andres; Mitchell, Phillip; Tornetta, Paul; Texas Christian University School of Medicine, Fort Worth, TX; ; Fort Worth Orthopedic Trauma Surgeons, Fort Worth, TX; ; Texas Christian University School of Medicine, Fort Worth, TX; ; Texas Orthopaedic Associates, Fort Worth, TX; ; Department of Orthopedic Surgery, University of Cincinnati, Cincinnati, OH; ; Department of Orthopedic Surgery, University of Missouri, Columbia, MO; ; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN; ; Department of Orthopedic Surgery, Stanford University, Redwood City, CA; ; Department of Orthopedic Surgery, University of Cincinnati, Cincinnati, OH; ; Department of Orthopedic Surgery, University of Cincinnati, Cincinnati, OH; ; Orthopaedic Trauma Service, Florida Orthopaedic Institute and University of South Florida, Tampa, FL; ; Fundació n Santa Fe de Bogotá , Bogotá , Colombia; ; Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN; and; Department of Orthopaedic Surgery, Boston Univers; (Journal of orthopaedic trauma, v.38, 2024, pp.403-409)
-
347
- Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression
- Zhang, Ke; Miorin, Lisa; Makio, Tadashi; Dehghan, Ishmael; Gao, Shengyan; Xie, Yihu; Zhong, Hualin; Esparza, Matthew; Kehrer, Thomas; Kumar, Anil; Hobman, Tom C.; Ptak, Christopher; Gao, Boning; Minna, John D.; Chen, Zhijian; Garcí a-Sastre, Adolfo; Ren, Yi; Wozniak, Richard W.; Fontoura, Beatriz M.A.; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235, USA.; Department of Biological Sciences, Hunter College, New York, NY 10065, USA.; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.; Department of Cell Biology, University of Alberta, Ed; (Science advances, v.7, 2021, pp.eabe7386)
-
348
- The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors
- Teichmann, Tom; Pflü ger‐ Mü ller, Beatrice; Gimé nez, Virna Margarita Martí n; Sailer, Fiona; Dirks, Henrik; Zehr, Simonida; Warwick, Timothy; Brettner, Felix; Munoz‐ Tello, Paola; Zimmer, Andreas; Tegeder, Irmgard; Thomas, Dominique; Gurke, Robert; Gü nther, Stefan; Heering, Jan; Proschak, Ewgenij; Geisslinger, Gerd; Bibli, Iris‐ S.; Heringdorf, Dagmar Meyer zu; Manucha, Walter; Windbergs, Maike; Knapp, Stefan; Weigert, Andreas; Leisegang, Matthias S.; Kojetin, Douglas; Brandes, Ralf P.; Goethe University Frankfurt Institute for Cardiovascular Physiology Frankfurt Germany; Goethe University Frankfurt Institute for Cardiovascular Physiology Frankfurt Germany; Instituto de Investigaciones en Ciencias Quí micas, Facultad de Ciencias Quí micas y Tecnoló gicas Universidad Cató lica de Cuyo San Juan Argentina; Institute of Biochemistry I, Faculty of Medicine Goethe University Frankfurt Frankfurt Germany; Goethe University Frankfurt Institute for Cardiovascular Physiology Frankfurt Germany; Goethe University Frankfurt Institute for Cardiovascular Physiology Frankfurt Germany; Goethe University Frankfurt Institute for Cardiovascular Physiology Frankfurt Germany; Institute of Pharmaceutical Technology Goethe University Frankfurt Frankfurt am Main Germany; Department of Biochemistry Vanderbilt University Nashville Tennessee USA; Institute of Molecular Psychiatry, Medical Faculty University of Bonn Bonn Germany; Institute of Clinical Pharmacology; (British journal of pharmacology : BJP, v.182, 2025, pp.1164-1182)
-
349
- An Atlas of Genetic Variation Linking Pathogen-Induced Cellular Traits to Human Disease
- Wang, Liuyang; Pittman, Kelly J.; Barker, Jeffrey R.; Salinas, Raul E.; Stanaway, Ian B.; Williams, Graham D.; Carroll, Robert J.; Balmat, Tom; Ingham, Andy; Gopalakrishnan, Anusha M.; Gibbs, Kyle D.; Antonia, Alejandro L.; Heitman, Joseph; Lee, Soo Chan; Jarvik, Gail P.; Denny, Joshua C.; Horner, Stacy M.; DeLong, Mark R.; Valdivia, Raphael H.; Crosslin, David R.; Ko, Dennis C.; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710, USA; Department of Biomedical Informatics and Medical Education, School of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710, USA; Department of Biomedical Informatics, School of Medicine, Vanderbilt University, Nashville, TN 37212, USA; Social Science Research Institute, Duke University, Durham, NC 27710, USA; Duke Research Computing, Duke University, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, School o; (Cell host & microbe, v.24, 2018, pp.308-323.e6)
-
350
- Association between unmet medication needs after hospital discharge and readmission or death among acute respiratory failure survivors: the addressing post-intensive care syndrome (APICS-01) multicenter prospective cohort study
- Brown, Samuel M.; Dinglas, Victor D.; Akhlaghi, Narjes; Bose, Somnath; Banner-Goodspeed, Valerie; Beesley, Sarah; Groat, Danielle; Greene, Tom; Hopkins, Ramona O.; Mir-Kasimov, Mustafa; Sevin, Carla M.; Turnbull, Alison E.; Jackson, James C.; Needham, Dale M.; Pulmonary and Critical Care Medicine, Intermountain Medical Center, Salt Lake City, UT USA; Outcomes After Critical Illness and Surgery (OACIS) Group and Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD USA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT USA; Beth Israel Deaconess Medical Center, Boston, MA USA; Beth Israel Deaconess Medical Center, Boston, MA USA; Pulmonary and Critical Care Medicine, Intermountain Medical Center, Salt Lake City, UT USA; Pulmonary and Critical Care Medicine, Intermountain Medical Center, Salt Lake City, UT USA; Biostatistics and Epidemiology, University of Utah, Salt Lake City, UT USA; Center for Humanizing Critical Care, Intermountain Medical Center, Salt Lake City, UT USA; Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT USA; Vanderbilt University Medical Center, Nashville, TN USA; Outcomes After Critical Illness and Surgery (OACIS) Group; (Critical care : CC, v.26, 2022, pp.6)
QUICK MENU
